Charntikov, S <br/><br/>
Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine.  [electronic resource] 

 -  Neuropharmacology  Dec 2013 
 - 138-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2013.07.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Conditioning, Operant--drug effects<br/>Dopamine--pharmacokinetics<br/>Dose-Response Relationship, Drug<br/>Drug Administration Routes<br/>Drug Interactions<br/>Goals<br/>Male<br/>Membrane Transport Modulators--administration & dosage<br/>Motor Activity--drug effects<br/>Nicotine--administration & dosage<br/>Nicotinic Agonists--administration & dosage<br/>Propylamines--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Self Administration<br/>Serotonin--pharmacokinetics<br/>Tritium--pharmacokinetics